Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: Sitemap: |
Title | EPIC Study: Official |
Description | The results are Learn more about the EPIC (Evaluation of Pimobendan In dogs with Cardiomegaly) Study, the largest veterinary cardiology study in |
Keywords | N/A |
WebSite | epictrial.com |
Host IP | 45.223.146.115 |
Location | - |
Site | Rank |
US$5,211,222
Last updated: 2023-05-10 04:05:27
epictrial.com has Semrush global rank of 2,031,060. epictrial.com has an estimated worth of US$ 5,211,222, based on its estimated Ads revenue. epictrial.com receives approximately 601,295 unique visitors each day. Its web server is located in -, with IP address 45.223.146.115. According to SiteAdvisor, epictrial.com is safe to visit. |
Purchase/Sale Value | US$5,211,222 |
Daily Ads Revenue | US$4,811 |
Monthly Ads Revenue | US$144,311 |
Yearly Ads Revenue | US$1,731,729 |
Daily Unique Visitors | 40,087 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
epictrial.com. | A | 43199 | IP: 45.223.146.115 |
epictrial.com. | A | 43199 | IP: 45.223.136.115 |
epictrial.com. | NS | 43200 | NS Record: ns2.observatoiredesmarques.fr. |
epictrial.com. | NS | 43200 | NS Record: ns3.nameshield.net. |
epictrial.com. | NS | 43200 | NS Record: obs.ns1.fr. |
epictrial.com. | MX | 43200 | MX Record: 0 mail.epictrial.com. |
epictrial.com. | TXT | 43200 | TXT Record: vtvq460dd1vfpmyjgl0s0bhblvzr0760 |
epictrial.com. | TXT | 43200 | TXT Record: google-site-verification=kzGMB6gQK2CSOWqMG1EamaSxZoo_kob_C-Hmudeh1J8 |
epictrial.com. | TXT | 43200 | TXT Record: globalsign-domain-verification=5DA2108FBE273F218924760E21DF0296 |
epictrial.com. | TXT | 43200 | TXT Record: q6bmlpw6pr32w6thc5kphtfmy5wytv2v |
epictrial.com. | TXT | 43200 | TXT Record: v=spf1 a mx ~all |
epictrial.com. | TXT | 43200 | TXT Record: vrs3qgrbbwp4h44dk6l1741qkz39by9c |
Epic study results 1 st EPIC STUDY PUBLICATION 2 nd EPIC STUDY PUBLICATION 3 rd EPIC STUDY PUBLICATION Why is the epic study important? Hear from the investigators What the epic study means for dogs and pet owners Diagnosing and managing preclinical MMVD About the epic study About the epic study Epic study design Epic study investigators Epic study locations Classification of canine heart disease Classification of canine heart disease Diagnosing preclinical MMVD Treatment options for heart disease FAQs ICVS Helpful links Contact The results are EPIC 1,2 Groundbreaking results of the EPIC (Evaluation of Pimobendan In dogs with Cardiomegaly) Study, the largest veterinary cardiology study in history, are now published. 15- month delay in time to composite primary endpoint compared with dogs receiving placebo* 60% more time in asymptomatic Stage B2 of heart disease* 10% more life without CHF signs that impact quality of life or cardiac-related death † PROVEN BENEFITS OF EARLY TREATMENT OF |
HTTP/1.1 301 Moved Permanently Location: https://epictrial.com/ Content-Length: 0 Connection: close HTTP/2 308 location: https://www.epictrial.com/ content-length: 0 strict-transport-security: max-age=31536000 HTTP/2 200 date: Tue, 02 Nov 2021 03:09:25 GMT server: Apache cache-control: no-cache set-cookie: XSRF-TOKEN=eyJpdiI6IloxaXlvZ0ZobE5PSTNSeUhuUE1kRFE9PSIsInZhbHVlIjoiV2NaYStpQUcrM1lQZFl3bFlNQlwvMVRLMXpGNkdoYm9VZCttanR6UmtRWTBWZjhxQWdKZnNUYk5QcjZjZ3hBZElNeHRUallxcThTVFpkMWFNeFY1ejNnPT0iLCJtYWMiOiIwNWNkYmVlYzAzNWQ3YmU1YThlZGM5MWRhMjczZDliZjU1YzQwOTc4MTUzZjUyNzc0NThlZjExNjI4ZGFkZjc1In0%3D; expires=Tue, 02-Nov-2021 05:09:25 GMT; Max-Age=7200; path=/ set-cookie: laravel_session=eyJpdiI6IkVRY1FHT0FxQXN3K3lGY3VSd2t5bHc9PSIsInZhbHVlIjoiWUduRDA4c3EzQTl2R3ZEYlZ6NEV6SmdEUHNWb0pGc05TcGM3MjZOOEdCZUp1YmpNd0xzSjBQNm5PemprZTVieThhbjRQaGFpMEhubk5hZ1FKSDNRV1E9PSIsIm1hYyI6IjU3YWU5ODhiYmFlZGM3YzRmMTZmMmZlN2YxMGQyYWViODI5MDgyOGI4MTI0OGIxNTNhY2VlOTMxYTk5NDIyNzMifQ%3D%3D; expires=Tue, 02-Nov-2021 05:09:25 GMT; Max-Age=7200; path=/; httponly vary: User-Agent content-type: text/html; charset=UTF-8 set-cookie: visid_incap_2638531=9WHExEZMSamWn153pALDQ+OrgGEAAAAAQUIPAAAAAABCBhZGAs2eIhEfJ/8qUruZ; expires=Tue, 01 Nov 2022 09:35:22 GMT; HttpOnly; path=/; Domain=.epictrial.com; Secure; SameSite=None set-cookie: incap_ses_1253_2638531=8pxNb0C9TiJ9ZbKeR41jEemogGEAAAAALjVdU0wYDJ6zQdXBsdvzOg==; path=/; Domain=.epictrial.com; Secure; SameSite=None strict-transport-security: max-age=31536000 x-cdn: Imperva x-iinfo: 10-34987459-34410676 pNNN RT(1635822563717 0) q(0 0 0 0) r(2 2) U5 |
Domain Name: EPICTRIAL.COM Registry Domain ID: 1604091143_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.nameshield.net Registrar URL: http://www.nameshield.net Updated Date: 2021-06-26T22:01:34Z Creation Date: 2010-06-28T14:13:26Z Registry Expiry Date: 2023-06-28T14:13:26Z Registrar: NAMESHIELD SAS Registrar IANA ID: 1251 Registrar Abuse Contact Email: abuse@nameshield.net Registrar Abuse Contact Phone: +33241182828 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS2.OBSERVATOIREDESMARQUES.FR Name Server: NS3.NAMESHIELD.NET Name Server: OBS.NS1.FR DNSSEC: unsigned >>> Last update of whois database: 2021-09-20T11:42:08Z <<< |